|
Federal
Register Notices >
Notices of Application - 2003 > Mallinckrodt, Inc.
FR Doc 03-7826
[Federal Register: April 2, 2003 (Volume 68, Number 63)]
[Notices]
[Page 16089-16090]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02ap03-132]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of
Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code
of Federal Regulations (CFR), this is notice that on January 14, 2003,
Mallinckrodt, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri
63147, made application by renewal to the Drug Enforcement Administration
(DEA) for registration as a bulk manufacturer of the basic classes of
controlled substance listed below:
| Drug |
Schedule |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Codeine (9050) |
II |
| Codeine-N-oxide (9053) |
I |
| Diprenorphine (9058) |
II |
[[Page 16090]]
| Drug |
Schedule |
| Etorphine HCl (9059) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9160) |
II |
| Dihydromorphine (9145) |
I |
| Hydromorphone (9150) |
II |
| Difenoxin (9168) |
I |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine (9180) |
II |
| Ecgonine (9180) |
II |
| Hydrocodone (9193) |
II |
| Heroin (9200) |
I |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Metopon (9260) |
II |
| Dextropropoxyphene, bulk (9273) |
II |
| Morphine (9300) |
II |
| Morphine-N-oxide (9307) |
I |
| Nicomorphine (9312) |
I |
| Normorphine (9313) |
I |
| Thebaine (9333) |
II |
| Opium extracts (9610) |
II |
| Opium fluid extract (9620) |
II |
| Norlevorphanol (9634) |
I |
| Opium tincture (9630) |
II |
| Opium, powdered (9639) |
II |
| Opium, granulated (9640) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
| Tetrahydrocannabinols (7370) |
I |
The firm plans to manufacture the controlled
substances as analytical reference standards to be used internally and for
sale to other companies.
Any other such applicant and any person who is
presently registered with DEA to manufacture such substances may file
comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in
quintuplicate, to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, DC 20537, Attention: Drug Operations Section,
Domestic Drug Unit (ODOD) and must be filed no later than 60 days from
publication.
Dated: March 14, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-7826 Filed 4-1-03; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
